Ontario

Quiénes somos

  • 5 de abril de 2022
    MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours
  • 5 de abril de 2022
    A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)
  • 5 de abril de 2022
    Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound